132 related articles for article (PubMed ID: 25706878)
1. Added value of arterial enhancement fraction color maps for the characterization of small hepatic low-attenuating lesions in patients with colorectal cancer.
Park M; Chung YE; Kim KA; Chung WS; Lee HS; Han KH; Kim MJ; Kim KW
PLoS One; 2015; 10(2):e0114819. PubMed ID: 25706878
[TBL] [Abstract][Full Text] [Related]
2. Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response.
Joo I; Lee JM; Kim KW; Klotz E; Han JK; Choi BI
Eur J Radiol; 2011 Dec; 80(3):e278-83. PubMed ID: 21251785
[TBL] [Abstract][Full Text] [Related]
3. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver.
Lee DH; Lee JM; Klotz E; Kim SJ; Kim KW; Han JK; Choi BI
Korean J Radiol; 2013; 14(1):51-60. PubMed ID: 23323031
[TBL] [Abstract][Full Text] [Related]
4. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma.
Kim KW; Lee JM; Klotz E; Park HS; Lee DH; Kim JY; Kim SJ; Kim SH; Lee JY; Han JK; Choi BI
Radiology; 2009 Feb; 250(2):425-434. PubMed ID: 19188314
[TBL] [Abstract][Full Text] [Related]
5. CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT.
Kim KW; Lee JM; Kim JH; Klotz E; Kim HC; Han JK; Choi BI
AJR Am J Roentgenol; 2011 Jan; 196(1):102-8. PubMed ID: 21178053
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Measurements of Enhancement on Preprocedure Triphasic CT Can Predict Response of Colorectal Liver Metastases to Radioembolization.
Boas FE; Brody LA; Erinjeri JP; Yarmohammadi H; Shady W; Kishore S; Sofocleous CT
AJR Am J Roentgenol; 2016 Sep; 207(3):671-5. PubMed ID: 27248430
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma Screening With Computed Tomography Using the Arterial Enhancement Fraction With Radiologic-Pathologic Correlation.
Huber AT; Schuster F; Ebner L; Bütikofer Y; Ott D; Leidolt L; Jöres A; Montani M; Heverhagen J; Christe A
Invest Radiol; 2016 Jan; 51(1):25-32. PubMed ID: 26619283
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
[TBL] [Abstract][Full Text] [Related]
9. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
[TBL] [Abstract][Full Text] [Related]
10. Do arterial phase helical CT images improve detection or characterization of colorectal liver metastases?
Ch'en IY; Katz DS; Jeffrey RB; Daniel BL; Li KC; Beaulieu CF; Mindelzun RE; Yao D; Olcott EW
J Comput Assist Tomogr; 1997; 21(3):391-7. PubMed ID: 9135646
[TBL] [Abstract][Full Text] [Related]
11. Real-time ultrasonography-computed tomography fusion imaging for staging of hepatic metastatic involvement in patients with colorectal cancer: initial results from comparison to US seeing separate CT images and to multidetector-row CT alone.
Stang A; Keles H; Hentschke S; Seydewitz C; Keuchel M; Pohland C; Dahlke J; Weilert H; Wessling J; Malzfeldt E
Invest Radiol; 2010 Aug; 45(8):491-501. PubMed ID: 20458251
[TBL] [Abstract][Full Text] [Related]
12. Volumetric arterial enhancement fraction predicts tumor recurrence after hepatic radiofrequency ablation of liver metastases: initial results.
Mahnken AH; Klotz E; Schreiber S; Bruners P; Isfort P; Günther RW; Wildberger JE
AJR Am J Roentgenol; 2011 May; 196(5):W573-9. PubMed ID: 21512047
[TBL] [Abstract][Full Text] [Related]
13. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
14. Revealing hepatic metastases from colorectal cancer: value of combined helical CT during arterial portography and CT hepatic arteriography with a unified CT and angiography system.
Inaba Y; Arai Y; Kanematsu M; Takeuchi Y; Matsueda K; Yasui K; Hoshi H; Itai Y
AJR Am J Roentgenol; 2000 Apr; 174(4):955-61. PubMed ID: 10749229
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
[TBL] [Abstract][Full Text] [Related]
17. Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT.
Tsurumaru D; Nishimuta Y; Muraki T; Asayama Y; Nishie A; Oki E; Honda H
Eur J Radiol; 2018 Nov; 108():165-171. PubMed ID: 30396650
[TBL] [Abstract][Full Text] [Related]
18. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
[TBL] [Abstract][Full Text] [Related]
19. Quantitative color mapping of the arterial enhancement fraction in patients with diffuse liver disease.
Kang SE; Lee JM; Klotz E; Kim KW; Kim JH; Han JK; Choi BI
AJR Am J Roentgenol; 2011 Oct; 197(4):876-83. PubMed ID: 21940575
[TBL] [Abstract][Full Text] [Related]
20. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
